{"id":"https://openalex.org/W165060328","doi":null,"title":"Linezolid Pharmacia Corp.","display_name":"Linezolid Pharmacia Corp.","alternate_titles":[],"publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W165060328","mag":"165060328","pmid":"https://pubmed.ncbi.nlm.nih.gov/11249571"},"language":"en","primary_location":{"id":"pmid:11249571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11249571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W165060328"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103583139","display_name":"John F. Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J F Barrett","raw_affiliation_strings":["Pharmaceutical Research and Development Division, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA. john.barrett@bms.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Division, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA. john.barrett@bms.com","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103583139"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":2.3205,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.87347212,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"1","issue":"2","first_page":"181","last_page":"187"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.37400001287460327,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.37400001287460327,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.35350000858306885,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.17900000512599945,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oxazolidinones","display_name":"oxazolidinones","score":0.9279999732971191},{"id":"https://openalex.org/keywords/antimicrobial-drug-development","display_name":"antimicrobial drug development","score":0.6159999966621399},{"id":"https://openalex.org/keywords/23s-rrna-mutations","display_name":"23S rRNA mutations","score":0.7820000052452087},{"id":"https://openalex.org/keywords/linezolid-resistance","display_name":"linezolid resistance","score":0.8009999990463257},{"id":"https://openalex.org/keywords/enterococcus","display_name":"Enterococcus","score":0.7039999961853027},{"id":"https://openalex.org/keywords/hospital-acquired-pneumonia","display_name":"nosocomial pneumonia","score":0.7129999995231628},{"id":"https://openalex.org/keywords/community-acquired-pneumonia","display_name":"community-acquired pneumonia","score":0.9359999895095825},{"id":"https://openalex.org/keywords/vancomycin-resistant-enterococci","display_name":"vancomycin-resistant enterococci","score":0.8379999995231628},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-sales-forecasting","display_name":"drug sales forecasting","score":0.4950000047683716},{"id":"https://openalex.org/keywords/pharmaceutical-marketing","display_name":"pharmaceutical marketing","score":0.35199999809265137},{"id":"https://openalex.org/keywords/pharmacia","display_name":"Pharmacia","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.946137547492981},{"id":"https://openalex.org/C40749294","wikidata":"https://www.wikidata.org/wiki/Q4631553","display_name":"23S ribosomal RNA","level":5,"score":0.804043173789978},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5975596904754639},{"id":"https://openalex.org/C2777677444","wikidata":"https://www.wikidata.org/wiki/Q140010","display_name":"Enterococcus faecium","level":3,"score":0.5833806991577148},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.5666733980178833},{"id":"https://openalex.org/C174802600","wikidata":"https://www.wikidata.org/wiki/Q12190","display_name":"Penicillin","level":3,"score":0.5137659311294556},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5105019807815552},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.46868351101875305},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4078722596168518},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3208032250404358},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.2880544662475586},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2345009744167328},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19675999879837036},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.10195103287696838},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.07352414727210999},{"id":"https://openalex.org/C88478588","wikidata":"https://www.wikidata.org/wiki/Q42244","display_name":"Ribosome","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000075202","descriptor_name":"Contraindications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11249571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11249571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:165060328","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11249571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1905878305","https://openalex.org/W2342137539","https://openalex.org/W2091080838","https://openalex.org/W2399250344","https://openalex.org/W2081422800","https://openalex.org/W3136772567","https://openalex.org/W4207045808","https://openalex.org/W7220436774","https://openalex.org/W2131909351","https://openalex.org/W1539546638"],"abstract_inverted_index":{"Linezolid":[0,75],"is":[1,59,134],"an":[2,55],"oxazolidinone":[3],"developed":[4],"by":[5,130,161],"Pharmacia":[6,8,179],"(formerly":[7],"&":[9],"Upjohn)":[10],"for":[11,122,136,181,204],"the":[12,31,41,49,113,123,139,184,228,231],"treatment":[13,124,140,185],"of":[14,48,51,125,141,186,227,237,251,272],"multi-resistant":[15],"Gram-positive":[16,131],"infections":[17,128,154,159],"[187765,317456].":[18],"It":[19,133],"binds":[20],"to":[21,78,189,206,212,233,258,279],"ribosomal":[22],"50S":[23],"subunits,":[24],"most":[25],"likely":[26],"within":[27,30],"domain":[28],"V":[29],"23S":[32,80],"rRNA":[33,81],"peptidyl":[34],"transferase":[35],"and":[36,92,119,148,151,155,168],"a":[37,79],"secondary":[38],"interaction":[39],"with":[40,89,96,127],"30S":[42],"subunit.":[43],"This":[44],"results":[45],"in":[46,85,106,138,183,216,235,255,262,276,283],"inhibition":[47],"initiation":[50],"protein":[52],"translation":[53],"at":[54],"early":[56],"point,":[57],"which":[58],"probably":[60],"N-formylmethionyl-tRNA":[61],"[335843].":[62],"No":[63],"direct":[64],"action":[65],"on":[66],"DNA":[67],"or":[68,195],"RNA":[69],"synthesis":[70],"has":[71],"been":[72],"observed":[73],"[220169].":[74],"resistance":[76],"due":[77,188],"mutation":[82],"may":[83,93],"emerge":[84],"Enterococci":[86],"during":[87],"therapy":[88],"this":[90],"antimicrobial,":[91],"be":[94,207],"associated":[95],"clinical":[97],"failure":[98],"[368652].":[99],"Following":[100],"FDA":[101,114],"approval,":[102],"linezolid":[103,116,182],"was":[104],"launched":[105],"May":[107,198],"2000":[108,205,256,277],"[368526,368652].":[109],"In":[110,197,219,242,265],"April":[111],"2000,":[112,199,221],"approved":[115],"injection,":[117],"tablets":[118],"oral":[120],"suspension":[121],"patients":[126],"caused":[129,160],"bacteria.":[132],"indicated":[135],"adults":[137],"nosocomial":[142],"pneumonia,":[143],"community-acquired":[144],"pneumonia":[145],"(CAP),":[146],"complicated":[147],"uncomplicated":[149],"skin":[150,152],"structure":[153],"vancomycin-resistant":[156],"enterococcus":[157],"(VRE)":[158],"methicillin-resistant":[162],"Staphylococcus":[163],"aureus":[164,193],"(MRSA),":[165],"VRE":[166],"faecium":[167],"penicillin-susceptible":[169],"Streptococcus":[170],"pneumoniae":[171],"[363503].":[172],"The":[173],"FDA,":[174],"however,":[175],"did":[176],"not":[177],"grant":[178],"indications":[180],"CAP":[187],"either":[190],"penicillin-resistant":[191],"S":[192],"(PRSA)":[194],"MRSA.":[196],"Merrill":[200],"Lynch":[201],"predicted":[202,223,249,270],"sales":[203,226,250,271],"US":[208,213,238,252,259,273,280],"$50":[209],"million,":[210],"rising":[211,257,278],"$760":[214],"million":[215,240,254,261,275,282],"2004":[217],"[366910].":[218],"February":[220,243],"P&U":[222],"that":[224],"peak":[225],"drug":[229],"had":[230],"potential":[232],"reach":[234],"excess":[236],"$750":[239],"[358429].":[241],"1999,":[244],"Morgan":[245],"Stanley":[246],"Dean":[247],"Witter":[248],"$40":[253],"$275":[260],"2005":[263],"[319855].":[264],"December":[266],"1998,":[267],"Deutsche":[268],"Bank":[269],"$100":[274],"$300":[281],"2002":[284],"[316769].":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W165060328","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
